AZD7325 is a potent and orally active partial selective PAM of GABAAalpha2 and Aalpha3 receptor (Ki=0.3 and 1.3 nM, respectively), and has less antagonistic efficacy at the Aalpha1 and Aalpha5 receptor subtypes[1][4]. AZD7325 is a moderate CYP1A2 and a potent CYP3A4 inducer in vitro[2]. AZD7325 has the potential for the investigation of anxiety and dravet syndrome[3]. PAM: positive allosteric modulator.
Molekulargewicht:
354.38
Reinheit:
99.95
CAS Nummer:
[942437-37-8]
Formel:
C19H19FN4O2
Target-Kategorie:
Cytochrome P450,GABA Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
